Biocon Taps 4 Bankers for Rs 4,500 Cr Capital Raise; Deal by Jan 2026

• Biocon plans to raise up to Rs 4,500 crore ($500 million) through a capital raise, likely via a QIP.
• Four investment banks (Kotak Mahindra Capital, Morgan Stanley, JP Morgan, HSBC Securities) have been appointed as advisors.
• The company aims to launch the deal by January 2026.
• Funds will primarily be used to finance the cash payment to Mylan for the integration of Biocon Biologics.
• Biocon's Board approved the fundraise proposal, which will be presented for EGM approval on December 31, 2025.

Why It Matters: Biocon's capital raise funds a major integration, impacting its financial future.